Cien por Cien Natural has introduced a pioneering omega-3 product that offers substantial benefits. This new offering, 'Krill Phospholipids PL+DHA,' represents a major advancement in omega-3 supplements due to its composition: a concentrated blend of docosahexaenoic acid (DHA) encapsulated in phospholipids.
These phospholipids are particularly noteworthy for their dual solubility—both water and fat-soluble—which facilitates superior emulsification and the formation of micelles. This process maximizes the surface area available for nutrient absorption.
To prove the effectiveness of this supplement, Aker BioMarine has conducted a clinical trial, the results of which have not yet been published, that demonstrates a tenfold improvement in the absorption of omega-3 fatty acids (both EPA and DHA) when formulated with PL+ phospholipids.
Image Credit: Iryna Pohrebna
What's Driving This Trend
- Enhanced Bioavailability
- Dual-solubility phospholipids significantly increase nutrient absorption and efficacy in dietary supplements.
- Clinical Trials on Nutritional Supplements
- Rigorous testing and validation through clinical trials are becoming a standard to establish effectiveness and gain consumer trust.
- Concentrated Nutrient Formulations
- High-concentration DHA encapsulated in innovative delivery systems is setting new standards in the omega-3 market.
Who This Affects Most
- Nutritional Supplements
- The introduction of dual-solubility components is revolutionizing the ease of nutrient absorption for consumers.
- Pharmaceuticals
- Phospholipid-based formulations present new opportunities for efficient drug delivery mechanisms.
- Functional Foods
- Innovations in nutrient delivery can enhance the health benefits and market appeal of fortified food products.
